Spencer Pharmaceutical Stock Forward View - Double Exponential Smoothing

SPPH Stock  USD 0.0001  0.00  0.00%   
Spencer Stock outlook is based on your current time horizon. We suggest always using this module together with an analysis of Spencer Pharmaceutical's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 3rd of February 2026 the rsi of Spencer Pharmaceutical's share price is below 20 . This usually implies that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Spencer Pharmaceutical's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Spencer Pharmaceutical, which may create opportunities for some arbitrage if properly timed.
Using Spencer Pharmaceutical hype-based prediction, you can estimate the value of Spencer Pharmaceutical from the perspective of Spencer Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors.
The Double Exponential Smoothing forecasted value of Spencer Pharmaceutical on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0.00 and the sum of the absolute errors of 0.00.

Spencer Pharmaceutical after-hype prediction price

    
  USD 1.0E-4  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Spencer Pharmaceutical to cross-verify your projections.
For more detail on how to invest in Spencer Stock please use our How to Invest in Spencer Pharmaceutical guide.

Spencer Pharmaceutical Additional Predictive Modules

Most predictive techniques to examine Spencer price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Spencer using various technical indicators. When you analyze Spencer charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Double exponential smoothing - also known as Holt exponential smoothing is a refinement of the popular simple exponential smoothing model with an additional trending component. Double exponential smoothing model for Spencer Pharmaceutical works best with periods where there are trends or seasonality.

Spencer Pharmaceutical Double Exponential Smoothing Price Forecast For the 4th of February

Given 90 days horizon, the Double Exponential Smoothing forecasted value of Spencer Pharmaceutical on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0.00, mean absolute percentage error of 0.00, and the sum of the absolute errors of 0.00.
Please note that although there have been many attempts to predict Spencer Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Spencer Pharmaceutical's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Spencer Pharmaceutical Stock Forecast Pattern

Backtest Spencer Pharmaceutical  Spencer Pharmaceutical Price Prediction  Research Analysis  

Spencer Pharmaceutical Forecasted Value

In the context of forecasting Spencer Pharmaceutical's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Spencer Pharmaceutical's downside and upside margins for the forecasting period are 0.0001 and 0.0001, respectively. We have considered Spencer Pharmaceutical's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.0001
0.0001
Downside
0.0001
Expected Value
0.0001
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Double Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Spencer Pharmaceutical stock data series using in forecasting. Note that when a statistical model is used to represent Spencer Pharmaceutical stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information CriteriaHuge
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0
MAPEMean absolute percentage error0.0
SAESum of the absolute errors0.0
When Spencer Pharmaceutical prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any Spencer Pharmaceutical trend in the prices. So in double exponential smoothing past observations are given exponentially smaller weights as the observations get older. In other words, recent Spencer Pharmaceutical observations are given relatively more weight in forecasting than the older observations.

Predictive Modules for Spencer Pharmaceutical

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Spencer Pharmaceutical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.00010.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.0000840.00
Details
Bollinger
Band Projection (param)
LowMiddleHigh
0.00010.00010.0001
Details

Spencer Pharmaceutical After-Hype Price Density Analysis

As far as predicting the price of Spencer Pharmaceutical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Spencer Pharmaceutical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Spencer Pharmaceutical, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Spencer Pharmaceutical Estimiated After-Hype Price Volatility

In the context of predicting Spencer Pharmaceutical's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Spencer Pharmaceutical's historical news coverage. Spencer Pharmaceutical's after-hype downside and upside margins for the prediction period are 0.00 and 0.00, respectively. We have considered Spencer Pharmaceutical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.0001
0.0001
After-hype Price
0.00
Upside
Spencer Pharmaceutical is very steady at this time. Analysis and calculation of next after-hype price of Spencer Pharmaceutical is based on 3 months time horizon.

Spencer Pharmaceutical Stock Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Spencer Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Spencer Pharmaceutical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Spencer Pharmaceutical, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
5 Events / Month
0 Events / Month
In about 5 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.0001
0.0001
0.00 
0.00  
Notes

Spencer Pharmaceutical Hype Timeline

Spencer Pharmaceutical is at this time traded for 0.0001. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Spencer is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Spencer Pharmaceutical is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company has price-to-book ratio of 0.35. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Spencer Pharmaceutical had not issued any dividends in recent years. The entity had 1:25 split on the 5th of October 2009. Given the investment horizon of 90 days the next projected press release will be in about 5 days.
Check out Historical Fundamental Analysis of Spencer Pharmaceutical to cross-verify your projections.
For more detail on how to invest in Spencer Stock please use our How to Invest in Spencer Pharmaceutical guide.

Spencer Pharmaceutical Related Hype Analysis

Having access to credible news sources related to Spencer Pharmaceutical's direct competition is more important than ever and may enhance your ability to predict Spencer Pharmaceutical's future price movements. Getting to know how Spencer Pharmaceutical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Spencer Pharmaceutical may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
IMMBImmunotech Laboratories 0.00 2 per month 0.00  0.00  0.00  0.00  0.00 
PXYNPraxsyn Corp 0.00 1 per month 0.00  0.00  0.00  0.00  0.00 
IPAHInterpharm Holdings 0.00 1 per month 0.00  0.00  0.00  0.00  0.00 
MHTXManhattan Scients 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
LRDSFLords Company Worldwide 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
REFGMedical Cannabis Pay 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
MEDVFMedivolve 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
BIOIFBiome Grow 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
CBGLCannabis Global 0.00 0 per month 0.00  0.08  100.00 (50.00) 150.00 
OPGXOptigenex 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 

Other Forecasting Options for Spencer Pharmaceutical

For every potential investor in Spencer, whether a beginner or expert, Spencer Pharmaceutical's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Spencer Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Spencer. Basic forecasting techniques help filter out the noise by identifying Spencer Pharmaceutical's price trends.

Spencer Pharmaceutical Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Spencer Pharmaceutical stock to make a market-neutral strategy. Peer analysis of Spencer Pharmaceutical could also be used in its relative valuation, which is a method of valuing Spencer Pharmaceutical by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Spencer Pharmaceutical Market Strength Events

Market strength indicators help investors to evaluate how Spencer Pharmaceutical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Spencer Pharmaceutical shares will generate the highest return on investment. By undertsting and applying Spencer Pharmaceutical stock market strength indicators, traders can identify Spencer Pharmaceutical entry and exit signals to maximize returns.

Story Coverage note for Spencer Pharmaceutical

The number of cover stories for Spencer Pharmaceutical depends on current market conditions and Spencer Pharmaceutical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Spencer Pharmaceutical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Spencer Pharmaceutical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
When determining whether Spencer Pharmaceutical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Spencer Pharmaceutical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Spencer Pharmaceutical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Spencer Pharmaceutical Stock:
Check out Historical Fundamental Analysis of Spencer Pharmaceutical to cross-verify your projections.
For more detail on how to invest in Spencer Stock please use our How to Invest in Spencer Pharmaceutical guide.
You can also try the AI Portfolio Prophet module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is there potential for Biotechnology market expansion? Will Spencer introduce new products? Factors like these will boost the valuation of Spencer Pharmaceutical. If investors know Spencer will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Spencer Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Assets
(1.42)
The market value of Spencer Pharmaceutical is measured differently than its book value, which is the value of Spencer that is recorded on the company's balance sheet. Investors also form their own opinion of Spencer Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Spencer Pharmaceutical's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Spencer Pharmaceutical's market value can be influenced by many factors that don't directly affect Spencer Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spencer Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Spencer Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Spencer Pharmaceutical's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.